DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma

BACKGROUND: DNA damage response (DDR) proficiency is the principal mechanism of temozolomide (TMZ) resistance in glioma. Accumulating evidence has also suggested the determining role of DDR in anticancer immunity. We propose that a comprehensive investigation of the DDR landscape can optimize glioma...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mu, Huang, Bingsong, Zhu, Lei, Wang, Qi, Pang, Ying, Cheng, Meng, Lian, Hao, Liu, Min, Zhao, Kaijun, Xu, Siyi, Zhang, Jing, Zhong, Chunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204352/
https://www.ncbi.nlm.nih.gov/pubmed/35720326
http://dx.doi.org/10.3389/fimmu.2022.875648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204352/
https://www.ncbi.nlm.nih.gov/pubmed/35720326
http://dx.doi.org/10.3389/fimmu.2022.875648

Ejemplares similares